¿¬±¸µ¿ÇâÁ¤º¸
Á¦¸ñ 2018³â Çѱ¹ÀÇÇÐ³í¹®µ¥ÀÌÅͺ£À̽º ±âÃÊÀÇÇÐ ¿¬±¸µ¿ÇâºÐ¼®
±Û¾´ÀÌ °ü¸®ÀÚ
÷ºÎÆÄÀÏ

2018³â Çѱ¹ÀÇÇÐ³í¹®µ¥ÀÌÅͺ£À̽º ±âÃÊÀÇÇÐ ¿¬±¸µ¿Ç⠺м® Å°¿öµå¸Ê Ŭ·¯½ºÆ®¸µºÐ¼®

 

¡à ºÐ¼®ÀÇ °³¿ä

 

2018³â Çѱ¹ÀÇÇÐ³í¹®µ¥ÀÌÅͺ£À̽º ±âÃÊÀÇÇÐ ¿¬±¸µ¿Ç⠺м®Àº µ¿½Ã ÃâÇö Å°¿öµå¸Ê°ú Áö½ÄÁöµµ Ŭ·¯½ºÆ®¸µ ºÐ¼®¸ÊÀ» ±¸ÇöÇÏ¿© ÀÌ·ç¾îÁ³´Ù. ÀÚ·á´Â Çѱ¹ÀÇÇÐ³í¹®µ¥ÀÌÅͺ£À̽º(KMbase)ÀÇ  2018³â Çѱ¹ÀÇÇÐ³í¹®µ¥ÀÌÅͺ£À̽º(KMbase) ¼­ÁöÁ¤º¸´Â Çѱ¹ÀÎ ¿¬±¸ÀÚ°¡ ±Ø³» ¹ßÇ¥ ¹× ±¹¿Ü¹ßÇ¥, ¹Ì±¹±¹¸³º¸°Ç¿ø(National Institute of Health)ÀÇ ±¹¸³ÀÇÇеµ¼­°üÀÎ PubMed¿¡ À妽ºµÈ Çѱ¹ÀÎ ¿¬±¸ÀÚ ³í¹®Á¤º¸ ÃÑ 13,3571°ÇÀ» ¼öÁý ºÐ·ùÇÏ¿© ÀÓ»óÀÇÇÐ, ±âÃÊÀÇÇÐ, ¿¹¹æÀÇÇÐ/º¸°ÇÇÐ, °£È£ÇÐ, Ä¡ÀÇÇÐ µî ÁÖ¿ä ÀÇ°úÇÐ Çй®ºÐ¾ßº°·Î  Å°¿öµå ¸Ê°ú Ŭ·¯½ºÅ͸µ Áö½ÄÁöµµ ³»Æ®¿öÅ© ºÐ¼®À» ½Ç½ÃÇÏ¿´´Ù.

 

ÀÇ°úÇкоßÀÇ 2018³â ¿¬±¸µ¿ÇâÀ» ÆľÇÇϱâ À§ÇØ ºÐ¼®¿¡¼­´Â ÀÇ°úÇבּ¸Á¤º¸¼¾ÅÍ(MedDRIC) DB¿¡¼­ ÀúÀÚÅ°¿öµå(¿µ¹®)¸¦ ÃßÃâ, À¯»ç¾î ¹× µ¿ÀǾî Á¤Á¦ °úÁ¤À» °ÅÃÄ ºÐ¾ßº° ÇÙ½É Å°¿öµå¸¦ ¼±Á¤ÇÏ¿´´Ù. ÇÙ½É Å°¿öµåÀÇ ³í¹® µ¿½ÃÃâÇö µ¥ÀÌÅ͸¦ È°¿ëÇÏ¿© VOSviewer¸¦ ÅëÇØ ¸ÅÇÎ(mapping) ¹× Ŭ·¯½ºÅ͸µ(clustering) ºÐ¼®À» ¼öÇàÇÏ°í °¡½ÃÈ­ ÇÏ¿´À¸¸ç, Ŭ·¯½ºÅ͸µ ºÐ¼®°á°ú¿¡ µû¸¥ ¿¬±¸ ÅäÇÈ °£ÀÇ µ¿½ÃÃâÇö °ü°è´Â Gephi¸¦ ÅëÇØ °¡½ÃÈ­ÇÏ¿´À¸¸ç, KISTIÀÇ ¹Ì·¡±â¼úºÐ¼®¼¾ÅÍ ¹ÚÁø¼­ ¹Ú»çÆÀ°ú Çù¾÷À» ÅëÇÏ¿© ÀÌ·ç¾îÁ³´Ù. ºÐ¼®¿¡¼­ Á¦¿Ü ½Ãų ¿ë¾î(exclusion list) ÃßÃâ°ú Å°¿öµå Á¤Á¦°úÁ¤À» ÅëÇÏ¿© ´Üº¹¼ö, µ¿ÀǾî, À¯»ç¾î word-bagÀ» »ý¼ºÇÏ¿´À¸¸ç,  Àü¹®°¡ °ËÅ並 ÅëÇÏ¿© Å°¿öµå µ¿½ÃÃâÇö¸Ê°ú Áö½ÄÁöµµ ¿¬±¸µ¿Çâ Å©·¯½ºÆ®¸µ ³×Æ®¿öÅ©¸¦ ÀÛ¼ºÇÏ¿´´Ù.

 

´Üº¹¼ö, µ¿ÀǾî, À¯»ç¾î µî¿¡ ´ëÇÑ Á¤Á¦ °úÁ¤À» °ÅÃÄ ÃÖÁ¾ ÀúÀÚÅ°¿öµå(¿µ¹®)´Â 71,034°³·Î ³ªÅ¸³µ´Ù.  ÀÌ °úÁ¤¿¡¼­ Áö³­ 2017³â Çѱ¹ÀÇÇÐ³í¹®(KMbase) ¿¬±¸µ¿Ç⠺м® ÀÛ¾÷À» ÅëÇØ ±¸ÃàÇÏ¿´´ø À¯ÀÇ¾î »çÀü 102°ÇÀÌ È°¿ëµÇ¾ú°í, À̹ø 2018³â ½Å±Ô ÀÛ¾÷À» ÅëÇÏ¿© 547°ÇÀÇ À¯ÀÇ¾î »çÀüÀ» »õ·Ó°Ô Ãß°¡ ±¸ÃàÇÏ¿´´Ù.   ºÐ¼®µ¥ÀÌÅÍ´Â KMbase 2018³â Çмú³í¹®Àº Àüü 46,006°Ç Áß Á¤Á¦°úÁ¤À» °ÅÃÄ 44,249ÆíÀ̾úÀ¸¸ç, ÀÌÁß ±âÃÊÀÇÇÐ ºÐ¾ßº° ³í¹® °Ç¼ö´Â 13,658Æí(30.86%)À» Â÷ÁöÇÏ¿´´Ù.

 

Çѱ¹ÀÇÇÐ ³í¹®µ¥ÀÌÅͺ£À̽º(KMbase) ±âÃÊÀÇÇÐ Top 10 Å°¿öµå µ¿½ÃÃâÇö

ºóµµ

apoptosis

214

Inflammasome/Inflammation

170

Antioxidant (activity/capacity/effect/enzyme/properties)

132

Oxidative stress

128

Cell adhesion/cycle/death/differentiation/migration/proliferation/signaling/theraphy/viability et al.

113

Biological Markers/Biomarker/Biological therapy/Genetics

99

Autophagy

98

Cancer/Neoplasms/Carcinoma

94

Anti-inflammation (agents/effect)

85

Mesenchymal Stem Cells

78

 

±×¸² 1) 2018³â  Çѱ¹ÀÇÇÐ³í¹®µ¥ÀÌÅͺ£À̽º(KMbase)  ±âÃÊÀÇÇÐ Å°¿öµå µ¿½ÃÃâÇö ¸Ê


 

±×¸² 2) 2018³â Çѱ¹ÀÇÇÐ³í¹®µ¥ÀÌÅͺ£À̽º(KMbase) ±âÃÊÀÇÇÐºÐ¾ß Å¬·¯½ºÆ®¸µ ³×Æ®¿öÅ© ºÐ¼®


2019-01-14 ¿ÀÀü 11:43:47, Á¶È¸¼ö : 1568